Literature DB >> 10910801

Fluoxetine for bulimia nervosa following poor response to psychotherapy.

B T Walsh1, W S Agras, M J Devlin, C G Fairburn, G T Wilson, C Kahn, M K Chally.   

Abstract

OBJECTIVE: This was an investigation of whether treatment with fluoxetine is useful for individuals with bulimia nervosa who do not respond to psychotherapy or relapse afterward.
METHOD: Twenty-two patients with bulimia nervosa who had not responded to, or had relapsed following, a course of cognitive behavior therapy or interpersonal psychotherapy were randomly assigned to receive placebo (N=9) or fluoxetine (60 mg/day, N=13) for 8 weeks.
RESULTS: The median frequency of binge eating in the previous 28 days declined from 22 to four episodes in the fluoxetine group but increased from 15 to 18 episodes in the placebo group. Similarly, purging frequency in the previous 28 days declined from 30 to six episodes in the fluoxetine group but increased from 15 to 38 episodes in the placebo group.
CONCLUSIONS: Fluoxetine may be a useful intervention for patients with bulimia nervosa who have not responded adequately to psychological treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910801     DOI: 10.1176/appi.ajp.157.8.1332

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

Review 1.  Extracts from "Clinical evidence": Bulimia nervosa.

Authors:  P J Hay; J Bacaltchuk
Journal:  BMJ       Date:  2001-07-07

Review 2.  Biological therapies for eating disorders.

Authors:  James E Mitchell; James Roerig; Kristine Steffen
Journal:  Int J Eat Disord       Date:  2013-07       Impact factor: 4.861

3.  Severity of bulimia nervosa and its impact on treatment outcome.

Authors:  Antonios Dakanalis; Santino Gaudio; Giuseppe Riva; Massimo Clerici
Journal:  Eat Weight Disord       Date:  2017-07-25       Impact factor: 4.652

Review 4.  Pharmacotherapy of eating disorders.

Authors:  Haley Davis; Evelyn Attia
Journal:  Curr Opin Psychiatry       Date:  2017-11       Impact factor: 4.741

Review 5.  Update on Treatments for Adolescent Bulimia Nervosa.

Authors:  Sasha Gorrell; Daniel Le Grange
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-07-04

6.  Early improvement during manual-guided cognitive and dynamic psychotherapies predicts 16-week remission status.

Authors:  P Crits-Christoph; M B Connolly; R Gallop; J P Barber; X Tu; M Gladis; L Siqueland
Journal:  J Psychother Pract Res       Date:  2001

7.  Experimental design and primary data analysis methods for comparing adaptive interventions.

Authors:  Inbal Nahum-Shani; Min Qian; Daniel Almirall; William E Pelham; Beth Gnagy; Gregory A Fabiano; James G Waxmonsky; Jihnhee Yu; Susan A Murphy
Journal:  Psychol Methods       Date:  2012-10-01

Review 8.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

9.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

Review 10.  Psychological treatments for bulimia nervosa and binging.

Authors:  Phillipa Pj Hay; Josué Bacaltchuk; Sergio Stefano; Priyanka Kashyap
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.